Showing results (51-60 of 156) with videos related to
Sort By:
Pageof 16
Healthcare (Basel, Switzerland)|June 24, 2022
The Impact of Telemedicine on Parkinson's Care during the COVID-19 Pandemic: An Italian Online SurveyFabiana Ruggiero, Linda Lombi, Maria Takeko Molisso, et al.Movement Disorders : Official Journal of the Movement Disorder Society|May 1, 2007
Gender differences in patients with Parkinson's disease treated with subthalamic deep brain stimulationEttore Accolla, Elena Caputo, Filippo Cogiamanian, et al.Molecular Cancer Research : MCR|August 6, 2020
Interplay Between V-ATPase G1 and Small EV-miRNAs Modulates ERK1/2 Activation in GBM Stem Cells and Nonneoplastic MilieuIrene Bertolini, Alessandra Maria Storaci, Andrea Terrasi, et al.Journal of Neurosurgical Sciences|September 21, 2021
Artificial intelligence-enhanced intraoperative neurosurgical workflow: current knowledge and future perspectivesLeonardo Tariciotti, Paolo Palmisciano, Martina Giordano, et al.Molecular and Cellular Endocrinology|January 7, 2019
Somatostatin analogs regulate tumor corticotrophs growth by reducing ERK1/2 activityDonatella Treppiedi, Elena Giardino, Rosa Catalano, et al.Pituitary|June 21, 2020
The suprasellar volume of nonfunctioning pituitary adenomas: a useful tool for predicting visual field deficitsGiulio Bonomo, Giulio A Bertani, Giorgio G Carrabba, et al.Cancer Letters|July 22, 2009
The dopamine-somatostatin chimeric compound BIM-23A760 exerts antiproliferative and cytotoxic effects in human non-functioning pituitary tumors by activating ERK1/2 and p38 pathwaysErika Peverelli, Luca Olgiati, Marco Locatelli, et al.Journal of Neuro-Oncology|March 16, 2007
Temozolomide in glioblastoma: results of administration at first relapse and in newly diagnosed cases. Is still proposable an alternative schedule to concomitant protocol?Manuela Caroli, Marco Locatelli, Rolando Campanella, et al.Life (Basel, Switzerland)|July 27, 2022
A Targeted Next-Generation Sequencing Panel to Genotype GliomasMaria Guarnaccia, Laura Guarnaccia, Valentina La Cognata, et al.European Cytokine Network|February 12, 2010
Human glioma tumors express high levels of the chemokine receptor CX3CR1Marco Locatelli, Leonardo Boiocchi, Stefano Ferrero, et al.Pageof 16